Best Peptide Protocols
    Recovery / HealingSingle

    TB-500 Fragment 17-23 10mg: Dosage, Reconstitution & Research Protocol Guide

    Dosing ranges, reconstitution steps, administration details, cycle length, and storage guidance for TB-500 Fragment 17-23 (10 mg Vial).

    Strength & Form:10 mg Vial
    TB-500 Fragment 17-23 (10 mg Vial) peptide vial

    TB-500 Fragment 17-23 (10 mg Vial)

    10 mg Research Peptide

    Quick Facts

    Type
    Single
    Category
    Recovery / Healing
    Vial Strength
    10 mg
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete TB-500 Fragment 17-23 10mg research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is TB-500 Fragment 17-23 10mg?

    TB-500 Fragment 17-23 10mg Vial Overview

    TB-500 Fragment (17-23), the Ac-SDKP sequence, is the minimal active fragment of Thymosin Beta-4 responsible for tissue-protective and anti-fibrotic effects. It retains potent anti-inflammatory activity, inhibits collagen deposition and TGF-β signaling, and promotes angiogenesis with improved bioavailability compared to full-length TB-500.

    TB-500 Fragment 17-23 10mg Quick Reference

    TB-500 Fragment 17-23 10mg Vial Specifications

    Peptide
    TB-500 Fragment 17-23 (10 mg Vial) (NNMT inhibitor)
    Vial Content
    10 mg total peptide
    Category
    Recovery / Healing
    Administration Method
    Subcutaneous injection
    Common Use Case
    Anti-fibrotic and tissue-protective research

    TB-500 Fragment 17-23 10mg Compared With Other Formats

    Details that distinguish this 10 mg format include:

    • Minimal active fragment of TB-4
    • Potent anti-fibrotic activity
    • Better bioavailability than full TB-500

    How Does TB-500 Fragment 17-23 Work?

    TB-500 Fragment 17-23 Mechanism of Action

    TB-500 Fragment (17-23), the Ac-SDKP sequence, is the minimal active fragment of Thymosin Beta-4. It retains potent anti-inflammatory activity, inhibits collagen deposition and TGF-β signaling, and promotes angiogenesis.

    What Are the Potential Benefits of TB-500 Fragment 17-23?

    TB-500 Fragment 17-23 Research Findings and Observed Outcomes

    Findings and reported areas of study for TB-500 Fragment 17-23 (10 mg Vial) include:

    • Anti-fibrotic effects
    • TGF-β inhibition
    • Angiogenesis promotion
    • Anti-inflammatory activity

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Reconstitute TB-500 Fragment 17-23 10mg?

    TB-500 Fragment 17-23 10mg Supplies for Reconstitution and Handling

    • •Insulin syringes (29–31g)
    • •Bacteriostatic water
    • •Alcohol prep pads
    • •Sharps container

    Supplies listed are for laboratory handling and research preparation purposes only.

    TB-500 Fragment 17-23 10mg Administration and Research Protocol

    TB-500 Fragment 17-23 Injection Route, Frequency and Timing

    RouteSubcutaneous injection
    FrequencyOnce daily
    TimingMorning or evening

    TB-500 Fragment 17-23 10mg Dosage Guide

    TB-500 Fragment 17-23 Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range500 mcg/day
    Standard Range1 mg/day
    Upper Range2 mg/day

    TB-500 Fragment 17-23 10mg Dosage to Syringe Units

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    500 mcg0.10 mL10 units
    1 mg0.20 mL20 units
    2 mg0.40 mL40 units

    This dosing table is unique to the 10 mg vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does a TB-500 Fragment 17-23 10mg Vial Last?

    TB-500 Fragment 17-23 10mg Duration by Research Dose

    At common research doses, one 10 mg vial of TB-500 Fragment 17-23 typically supports:

    500 mcg/day~20 days
    1 mg/day~10 days
    2 mg/day~5 days

    How to Reconstitute TB-500 Fragment 17-23 10mg

    TB-500 Fragment 17-23 10mg Reconstitution With Bacteriostatic Water

    This section applies specifically to the TB-500 Fragment 17-23 (10 mg Vial).

    Recommended Diluent
    Bacteriostatic water
    Diluent Volume
    2 mL
    Final Concentration
    5 mg/mL

    TB-500 Fragment 17-23 10mg Mixing Instructions

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    TB-500 Fragment 17-23 Stacks and Research Combinations

    TB-500 Fragment 17-23 and Compatible Research Pairings

    In research settings, TB-500 Fragment 17-23 (10 mg Vial) is sometimes paired with peptides such as:

    • BPC-157: Comprehensive tissue repair

    Factors That May Affect TB-500 Fragment 17-23 Research Outcomes

    Supporting Factors for TB-500 Fragment 17-23 Research

    Factors recorded alongside this protocol include:

    • Anti-inflammatory diet
    • Moderate exercise
    • Adequate rest

    These factors can affect how research observations are interpreted.

    TB-500 Fragment 17-23 Side Effects and Safety Considerations

    TB-500 Fragment 17-23 10mg Tolerability Notes

    Generally well-tolerated.

    Some individuals report:

    • Mild injection site reactions
    • Temporary redness

    How to Store TB-500 Fragment 17-23 Before and After Reconstitution

    TB-500 Fragment 17-23 10mg Storage Requirements

    Unreconstituted
    Refrigerate or freeze
    Reconstituted
    Refrigerate at 2–8°C
    Post-Mix Stability
    Up to 4 weeks

    Who Should Avoid TB-500 Fragment 17-23?

    This peptide is generally not recommended for:

    • Pregnant/breastfeeding
    • Active cancer (promotes angiogenesis)

    TB-500 Fragment 17-23 10mg FAQs

    How does TB-500 Fragment differ from full TB-500?

    The fragment (Ac-SDKP) is the minimal active sequence retaining anti-fibrotic and anti-inflammatory effects with better bioavailability due to its smaller size.

    Where to Buy TB-500 Fragment 17-23 10mg for Research

    TB-500 Fragment 17-23 10mg Purchasing and Research Supply Notes

    Before ordering TB-500 Fragment 17-23 (10 mg Vial), review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Recovery / Healing Peptides

    ARA-290 (16 mg Vial) productARA-290 (16 mg Vial)BPC-157 (5 mg Vial) productBPC-157 (5 mg Vial)BPC-157 (10 mg Vial) productBPC-157 (10 mg Vial)Cartalax (25 mg Vial) productCartalax (25 mg Vial)KPV (10 mg Vial) productKPV (10 mg Vial)LL-37 (5 mg Vial) productLL-37 (5 mg Vial)